Skip to content

Eucerin controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile4 entries

  1. 2026

    Eucerin Hyaluron-Filler Epigenetic Serum advertisement banned in the United Kingdom

    The UK advertising regulator found that an advertisement’s claim that the serum could make users look up to five years younger was misleading because the supporting four-week consumer study relied on participants’ perceptions rather than demonstrating the advertised outcome in the claimed manner.

  2. 2026

    Hyaluron-Filler Epigenetic Serum advertising ruling

    The UK advertising regulator banned a billboard claiming that Eucerin’s £49 serum could make users look up to five years younger. The ruling reported that the supporting study involved 160 participants using the product for four weeks and then assessing how much younger they believed they looked; the regulator considered the advertisement misleading.

  3. 2026

    Eucerin serum advertisement banned over 'up to five years younger' claim

    The UK Advertising Standards Authority upheld a complaint concerning a billboard for Eucerin Hyaluron-Filler Epigenetic Serum. The advertisement described the product as clinically proven to make users look up to five years younger. The regulator found the supporting evidence insufficient, citing methodological concerns including the absence of a control group and reliance on unpublished studies. Beiersdorf said the billboard was no longer running and maintained that its products are supported by scientific research.

  4. 2026

    UK ASA bans Epigenetic Serum billboard claim

    The UK Advertising Standards Authority ruled that a billboard claim that the serum could make users look up to five years younger was misleading. The regulator questioned the study design, including the lack of a control group, participant recruitment information and the use of unpublished supporting research.